Payment overview · 2025
General Payments
$100.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Susan Reyes, MD
Allopathic & Osteopathic Physicians|Internal Medicine · KNOXVILLE, TN · NPI 1902834203
Verified facts
What the public records show
CMS Open Payments records show Susan Reyes, MD received $100.00 in general payments during 2025 across 1 reported records.
E.R. Squibb & Sons, L.L.C. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 219 claims for Eliquis by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | Unresolved — no canonical attribution shown | $100.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $100.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| COBENFY Normalized: cobenfy |
Drug | E.R. Squibb & Sons, L.L.C. | $100.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
219 | 58 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Gabapentin | Gabapentin | 930 | 154 |
| Levothyroxine Sodium | Levothyroxine Sodium | 593 | 160 |
| Atorvastatin Calcium | Atorvastatin Calcium | 491 | 141 |
| Amlodipine Besylate | Amlodipine Besylate | 446 | 123 |
| Furosemide | Furosemide | 417 | 139 |
| Lisinopril | Lisinopril | 388 | 117 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 384 | 69 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 370 | 141 |
| Omeprazole | Omeprazole | 352 | 108 |
| Potassium Chloride | Potassium Chloride | 321 | 115 |
| Pantoprazole Sodium | Pantoprazole Sodium | 315 | 94 |
| Sertraline Hcl | Sertraline Hcl | 295 | 81 |
| Metoprolol Tartrate | Metoprolol Tartrate | 287 | 81 |
| Trazodone Hcl | Trazodone Hcl | 264 | 72 |
| Oxycodone Hcl | Oxycodone Hcl | 256 | 34 |
| Metformin Hcl | Metformin Hcl | 233 | 57 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 226 | 39 |
| Eliquis | Apixaban | 219 | 58 |
| Losartan Potassium | Losartan Potassium | 214 | 62 |
| Tamsulosin Hcl | Tamsulosin Hcl | 207 | 56 |
| Nystatin | Nystatin | 190 | 82 |
| Quetiapine Fumarate | Quetiapine Fumarate | 189 | 53 |
| Tramadol Hcl | Tramadol Hcl | 178 | 57 |
| Mirtazapine | Mirtazapine | 174 | 47 |
| Clopidogrel | Clopidogrel Bisulfate | 172 | 49 |
| Montelukast Sodium | Montelukast Sodium | 165 | 50 |
| Pregabalin | Pregabalin | 164 | 37 |
| Donepezil Hcl | Donepezil Hcl | 163 | 48 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 161 | 16 |
| Fluticasone Propionate | Fluticasone Propionate | 158 | 65 |
| Duloxetine Hcl | Duloxetine Hcl | 153 | 38 |
| Alprazolam | Alprazolam | 144 | 28 |
| Ondansetron Hcl | Ondansetron Hcl | 142 | 65 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 140 | 39 |
| Bumetanide | Bumetanide | 135 | 42 |
| Escitalopram Oxalate | Escitalopram Oxalate | 134 | 47 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 134 | 101 |
| Baclofen | Baclofen | 133 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 132 | 40 |
| Famotidine | Famotidine | 129 | 36 |
| Ropinirole Hcl | Ropinirole Hcl | 128 | 33 |
| Meloxicam | Meloxicam | 125 | 35 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 122 | 51 |
| Hydrochlorothiazide | Hydrochlorothiazide | 121 | 42 |
| Ozempic | Semaglutide | 121 | 29 |
| Buspirone Hcl | Buspirone Hcl | 118 | 45 |
| Fluconazole | Fluconazole | 116 | 55 |
| Prednisone | Prednisone | 113 | 48 |
| Allopurinol | Allopurinol | 111 | 32 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 111 | 76 |
| Promethazine Hcl | Promethazine Hcl | 109 | 32 |
| Amoxicillin | Amoxicillin | 108 | 79 |
| Azithromycin | Azithromycin | 108 | 85 |
| Carvedilol | Carvedilol | 107 | 41 |
| Memantine Hcl | Memantine Hcl | 102 | 28 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 100 | 80 |
| Levetiracetam | Levetiracetam | 99 | 24 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 99 | 28 |
| Tizanidine Hcl | Tizanidine Hcl | 97 | 32 |
| Levofloxacin | Levofloxacin | 96 | 70 |
| Methylprednisolone | Methylprednisolone | 95 | 67 |
| Lorazepam | Lorazepam | 90 | 24 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 87 | 34 |
| Divalproex Sodium | Divalproex Sodium | 86 | 28 |
| Diclofenac Sodium | Diclofenac Sodium | 83 | 42 |
| Pravastatin Sodium | Pravastatin Sodium | 83 | 25 |
| Doxycycline Hyclate | Doxycycline Hyclate | 82 | 63 |
| Glimepiride | Glimepiride | 82 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 78 | 29 |
| Mounjaro | Tirzepatide | 78 | 18 |
| Simvastatin | Simvastatin | 77 | 19 |
| Warfarin Sodium | Warfarin Sodium | 76 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 74 | 28 |
| Clonidine Hcl | Clonidine Hcl | 72 | 19 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 71 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 70 | 22 |
| Ondansetron Odt | Ondansetron | 69 | 32 |
| Olanzapine | Olanzapine | 68 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 67 | 47 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 64 | 18 |
| Lovastatin | Lovastatin | 63 | 19 |
| Ibuprofen | Ibuprofen | 62 | 26 |
| Linzess | Linaclotide | 62 | 17 |
| Cephalexin | Cephalexin | 60 | 49 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 60 | 32 |
| Alendronate Sodium | Alendronate Sodium | 59 | 15 |
| Jardiance | Empagliflozin | 59 | 20 |
| Spironolactone | Spironolactone | 58 | 19 |
| Xarelto | Rivaroxaban | 58 | 14 |
| Finasteride | Finasteride | 57 | 17 |
| Meclizine Hcl | Meclizine Hcl | 57 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 55 | 16 |
| Oxybutynin Chloride | Oxybutynin Chloride | 53 | 14 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 48 | 14 |
| Sucralfate | Sucralfate | 47 | 15 |
| Myrbetriq | Mirabegron | 45 | 21 |
| Metformin Hcl Er | Metformin Hcl | 44 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 44 | suppressed |
| Topiramate | Topiramate | 44 | 16 |
| Bupropion Xl | Bupropion Hcl | 43 | 17 |
| Mupirocin | Mupirocin | 41 | 33 |
| Spiriva Handihaler | Tiotropium Bromide | 41 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 40 | 11 |
| Diazepam | Diazepam | 39 | suppressed |
| Lamotrigine | Lamotrigine | 39 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 39 | 14 |
| Clonazepam | Clonazepam | 37 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 37 | 11 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 36 | suppressed |
| Risperidone | Risperidone | 36 | 14 |
| Symbicort | Budesonide/Formoterol Fumarate | 36 | 13 |
| Ezetimibe | Ezetimibe | 35 | 15 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 35 | suppressed |
| Celecoxib | Celecoxib | 34 | 12 |
| Lacosamide | Lacosamide | 34 | suppressed |
| Methocarbamol | Methocarbamol | 34 | 12 |
| Atenolol | Atenolol | 33 | 14 |
| Glipizide Er | Glipizide | 32 | suppressed |
| Cefdinir | Cefdinir | 30 | 24 |
| Entresto | Sacubitril/Valsartan | 30 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 28 | 14 |
| Brilinta | Ticagrelor | 28 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 28 | 13 |
| Trulicity | Dulaglutide | 28 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 28 | 12 |
| Zubsolv | Buprenorphine Hcl/Naloxone Hcl | 27 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 26 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 26 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | 11 |
| Gentamicin Sulfate | Gentamicin Sulfate | 26 | 11 |
| Rizatriptan | Rizatriptan Benzoate | 26 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 25 | suppressed |
| Nystop | Nystatin | 25 | 14 |
| Diltiazem 24hr Er | Diltiazem Hcl | 24 | suppressed |
| Colchicine | Colchicine | 23 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 22 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 22 | suppressed |
| Glipizide | Glipizide | 22 | suppressed |
| Januvia | Sitagliptin Phosphate | 22 | suppressed |
| Valsartan | Valsartan | 22 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 22 | suppressed |
| Aripiprazole | Aripiprazole | 21 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 21 | suppressed |
| Digoxin | Digoxin | 21 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | 11 |
| Solifenacin Succinate | Solifenacin Succinate | 21 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 20 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 20 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Temazepam | Temazepam | 20 | suppressed |
| Gemfibrozil | Gemfibrozil | 19 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 19 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 19 | 11 |
| Primidone | Primidone | 19 | suppressed |
| Ramipril | Ramipril | 19 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 18 | suppressed |
| Gemtesa | Vibegron | 18 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 18 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 18 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Humalog | Insulin Lispro | 17 | suppressed |
| Nitroglycerin | Nitroglycerin | 17 | 11 |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 17 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 16 | suppressed |
| Novolog Flexpen | Insulin Aspart | 16 | suppressed |
| Ramelteon | Ramelteon | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 16 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Cefepime Hcl | Cefepime Hcl | 14 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Latanoprost | Latanoprost | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Amantadine | Amantadine Hcl | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Calcitriol | Calcitriol | 12 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 12 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 12 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 12 | suppressed |
| Methylprednisolone Sodium Succ | Methylprednisolone Sod Succ | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 11 | suppressed |
| Haloperidol | Haloperidol | 11 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Phenytoin | Phenytoin | 11 | suppressed |
| Vraylar | Cariprazine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $100.00 · 1 records | E.R. Squibb & Sons, L.L.C. | COBENFY | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with E.R. Squibb & Sons, L.L.C.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error